Great Lakes Clinical Trials is currently enrolling participants for a research study of an investigational medication for the treatment of Atopic Dermatitis
Atopic dermatitis is the most common type of eczema. More than 18 million American adults have atopic dermatitis. "Dermatitis" refers to a condition of the skin and "atopic" relates to diseases caused by allergic reactions.
During a flare, Atopic Dermatitis becomes a red, itchy rash which often appears on the cheeks, arms and legs. Many different physical and internal factors can trigger an eczema flare-up. The resulting inflammation causes increased blood flow and the urge to itch.
What is this trial studying?
Although treatments are already available to treat atopic dermatitis, soem people do not see an adequate improvement or do not tolerate the prescription medication. Great Lakes Clinical Trials is recruiting participants to find out more about the safety and effectiveness of an investigational study drug in adolescents and adults with moderate to severe atopic dermatitis.
To qualify, participants must:
• Be between the ages of 12 and 75
• Have had moderate to severe atopic dermatitis, with itching, for at least the past three years.
• had had poor response to treatments that are applied to your skin.
Other entry criteria may apply and will be reviewed, prior to participation.
What will participation involve?
Participation with last for just under 3 years. At the beginning the visits to the clinic will be every 1-2 weeks. Visits become less frequent after a few months
You will receive all study-related care and study-related drug at no cost. For your participation, you will receive a stipend of $75 for each clinic visit you complete, up to $1,500 for completing the study.
If you are interested in joining this trial, click on the "Sign Up" button below to provide your contact information. One of our staff will be in touch with you within 24 hrs to conduct a short phone screen to determine your eligibility. Otherwise, you can call our center directly at (773) 275-3500 to speak with one of our staff today.